Key findings included: Nearly 16% non-placebo-adjusted weight loss on 2.4 mg weekly berobenatide No weight-loss plateau observed through 32 weeks of extension treatment Successful transition from weekly induction to monthly maintenance dosing Favorable gastrointestinal tolerability despite rapid dose escalation These results provide proof-of-concept for monthly GLP-1 therapy while maintaining competitive efficacy
Stimulant neurons are represented by neuropeptide Y (NPY) and agouti-related peptide (AgRP), while inhibitors include alpha-melanocyte stimulating hormone (alpha-MSH) and cocaine- and amphetamine-regulated transcript (CART)
Patients visiting us from Beverly Hills, Hollywood, and the Santa Monica Blvd area consistently report life-changing improvements that extend well beyond the scale
For that reason, for all patients that are deemed candidates (more on this in a minute), we recommend you join our 6-month weight management program to get a health assessment, including initial bloodwork, followed by weekly coaching sessions
One method is through the use of a saturated steam autoclave
For long-term stability, store at 20 C with desiccant
